{
  "docId": "019de070-a24a-718d-8fa7-de49d427834d",
  "docSlug": "119c472f2b470327a8fb07de55a72f86",
  "documentTitle": "Alkermes | Results Presentation Deck | 15 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 15,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "key_messages",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Uses a numbered process-style chevron layout to organize strategic priorities.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-a24a-718d-8fa7-de49d427834d/5",
  "deckHref": "/decks/019de070-a24a-718d-8fa7-de49d427834d",
  "deckJsonHref": "/decks/019de070-a24a-718d-8fa7-de49d427834d.json",
  "deckAnchorHref": "/decks/019de070-a24a-718d-8fa7-de49d427834d#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.875,
        "x": 0.063,
        "y": 0.235
      },
      "kind": "diagram",
      "text": "1. Grow and Diversify Commercial Revenues; 2. Demonstrate Value of R&D Investments; 3. Manage for Growth & Long-Term Profitability",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "047043d5-5cfd-4708-9eab-47dcffe20176",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.675,
        "y": 0.495
      },
      "kind": "list",
      "text": "Operationalize commitment to profitability targets; Optimize cost structure and drive operating leverage; Explore strategic opportunities to maximize value and enhance profitability",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0b9c17b1-9c13-4e9a-a23a-a9cd1dba4b5c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.075,
        "y": 0.495
      },
      "kind": "list",
      "text": "Drive VIVITROL and ARISTADA net sales; Support VUMERITY growth; Launch LYBALVI",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9327863b-920b-4399-9332-0046210a0b85",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.25,
        "x": 0.375,
        "y": 0.495
      },
      "kind": "list",
      "text": "Nemvaleukin alfa: Determine registration pathway, Demonstrate anti-tumor activity, Explore strategic collaboration; ALKS 1140: Initiate phase 1/FIH study; Investor Day: Provide update on pipeline",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c27b0ec1-aa6e-42f3-9791-2c91bfb4a785",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.038,
        "y": 0.89
      },
      "kind": "source-note",
      "text": "*Prescription Drug User Fee Act **Co-repressor of repressor element-1 silencing transcription factor",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1fe32638-12f8-41df-bc21-30aadccdda70",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.048,
        "w": 0.785,
        "x": 0.038,
        "y": 0.105
      },
      "kind": "title",
      "text": "Focus on Value Creation in 2021: Three Key Components",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "63837bc7-29a7-4519-8dfd-96f7e33c544d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "strategic-pillars",
      "slug": null,
      "matchId": "a194d82e-8994-426b-bf7d-9e216829bab5",
      "evidence": "Three numbered components defining the 2021 strategy",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 5,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "a1069669-aa83-4169-84a2-49a8402dd202",
      "evidence": "The presentation emphasizes the focus on value creation in 2021",
      "position": 0,
      "objective": "Highlight the importance of Alkermes' strategic priorities",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}